-
Conducting a clinical trial for COVID-19 medical devices: List of authorized...
The table below lists the clinical trials authorized by Health Canada for COVID-19-related medical devices. -
Improve indoor air quality
Find out how to imporve indoor air quality -
Novel Food Information - Acrylamide-reducing Baker’s Yeast
Health Canada has notified Renaissance BioScience Corporation that it has no objection to the food use of acrylamide-reducing baker's yeast, RBSC AR. The Department conducted a... -
Letters to DIN Owners
In the event of an anticipated or actual drug shortage, Health Canada may issue letters to DIN owners that have failed to provide notification to the public on the Canadian Drug... -
Guidelines for Canadian Drinking Water Quality: Guideline Technical Document...
This guideline technical document reviews and assesses the identified health risks associated with cyanobacterial toxins in drinking water. It assesses new studies and... -
Human Health Risk Assessment for Inhaled Manganese: document summary
Manganese (CAS 7439-96-5) is a metal that is found naturally in air, water, soil and in living systems. Biologically, manganese (Mn) is an essential mineral and is required for... -
Novel Food Information: Abiotic Stress and Herbicide Tolerant HB4 Soybean...
Health Canada has notified Bioceres Crop Solutions Corp. that it has no objection to the food use of Abiotic Stress and Herbicide Tolerant HB4 Soybean. The Department conducted... -
Notice: Prescription Drug List (PDL): Sotrovimab (COVID-19)
The purpose of this Notice of Amendment is to notify about the addition of sotrovimab to the Prescription Drug List (PDL) for human and veterinary use. -
Sustainable Pest Management
Sustainable pest management (SPM) is designed to meet society's current and future needs for the protection of human health and the environment for the production of food, feed... -
Cannabis: Intra-industry sale and distribution
Infographic depicting the sale and distribution of cannabis between different licence holders. -
Guidance on Medical Device Establishment Licensing (GUI-0016)
This guidance document is intended for any person in the medical device industry and it provides guidance on regulatory requirements in relation to Medical Device Establishment... -
Medical device shortages: Overview
A medical device shortage occurs when a manufacturer is unable to meet Canadian market demand for the device or for its components, accessories, parts or consumable materials.... -
Drugs and vaccines for COVID-19: List of authorized clinical trials
The tables below list the COVID-19-related clinical trials which have been authorized by Health Canada through the Food and Drug Regulations or the Interim order No. 2 for... -
Proposed Registration Decision PRD2022-16, Ozone Generating Device lotus PRO
This summary describes the key points of the evaluation, while the Science evaluation of Proposed Registration Decision PRD2022-16, Ozone Generating Device lotus PRO provides... -
Information on Drug Shortages
Notification and communication of drug shortages by drug manufacturers and importers is an essential component of preventing and mitigating shortages. Timely and public... -
Guidelines for Canadian Drinking Water Quality - Summary Tables (Updated...
The tables in this document summarize the values and key information from each of the guidelines. Health Canada updates the summary tables regularly, but you should always... -
Fatty Acids and Derivatives Group – information sheet
Substances in the Fatty Acids and Derivatives Group may be associated with certain human health and/or ecological effects; however, the risk to Canadians and the environment is... -
Guidance for Evaluating Human Health Impacts in Environmental Assessment:...
This document provides generic guidance on the need for conducting a human health risk assessment (HHRA) in federal assessments of proposed major resource and infrastructure... -
Health Canada – Standing Committee on Health - Minister of health Briefing...
Appearance of the Minister of Health Before HESA on the Supps C